Physiomics (GB:PYC) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Physiomics plc, a leader in mathematical modelling and biostatistics, has released its end-of-year results presentation on its website, showcasing its role in supporting drug development and personalized medicine. The company continues to leverage its cutting-edge Virtual Tumour technology, having influenced over 100 commercial projects with major clients like Merck KGaA and CRUK. Investors can access the latest insights into the company’s strategic direction and market position via the updated presentation.
For further insights into GB:PYC stock, check out TipRanks’ Stock Analysis page.